As expected, IDH-mutant gliomas manifested increased methylation concomitant with decreased expression of IGFBP2, YAP1, and WWTR1 in comparison with IDH-wildtype (Figures 2A and 4A). This evidence concerns the gene YAP1 and central nervous system cancer.